October 27, 2020
NineSigma, representing a Japanese pharmaceutical company, seeks novel drug seeds that can be applied to the treatment of intractable and refractory autoimmune diseases. While proposals for a drug candidate compound are preferred, those with novel unique mechanisms, concepts, or ideas are also welcome to participate. The client, specializing in autoimmune diseases […]
